Cellebrite DI (CLBT) Non-Current Deffered Revenue (2020 - 2025)

Cellebrite DI (CLBT) has reported Non-Current Deffered Revenue for 6 consecutive years, with $49.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Non-Current Deffered Revenue rose 9.46% year-over-year to $49.5 million; the TTM figure through Dec 2025 stood at $49.5 million (up 9.46% YoY), while the FY2025 annual figure was $49.5 million, up 9.46% from the prior year.
• Non-Current Deffered Revenue came in at $49.5 million for Q4 2025 at Cellebrite DI, up from $45.2 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $49.5 million in Q4 2025, with the low at $34.4 million in Q3 2021.
• Average Non-Current Deffered Revenue over 5 years is $42.5 million, with a median of $43.7 million recorded in 2022.
• Across the five-year window, Non-Current Deffered Revenue rose 15.78% in 2022 and dropped 3.93% in 2024, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $36.4 million in 2021, then increased by 15.78% to $42.2 million in 2022, then climbed by 11.68% to $47.1 million in 2023, then retreated by 3.93% to $45.2 million in 2024, then advanced by 9.46% to $49.5 million in 2025.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $49.5 million, $45.2 million, and $47.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.